Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paba-Prada CE"'
Publikováno v:
Clinical Pharmacology & Therapeutics; Jan2017, Vol. 101 Issue 1, p81-88, 8p
Autor:
Hari P; Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: phari@mcw.edu., Paba-Prada CE; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: ClaudiaPab@baptisthealth.net., Voorhees PM; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: peter.voorhees@atriumhealth.org., Frye J; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA. Electronic address: giovanni@sbcglobal.net., Chang YL; Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA, USA. Electronic address: cylchang@gmail.com., Moreau P; University Hospital, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr., Zonder J; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA. Electronic address: zonderj@karmanos.org., Boccia R; Center for Cancer and Blood Disorders, Bethesda, MD, USA. Electronic address: rboccia@ccbdmd.com., Shain KH; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: ken.shain@moffitt.org.
Publikováno v:
Leukemia research [Leuk Res] 2019 Aug; Vol. 83, pp. 106172. Date of Electronic Publication: 2019 Jun 17.
Autor:
O'Donnell EK; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Laubach JP; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Yee AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mass General/North Shore Cancer Center, Danvers, MA, USA., Chen T; Dana-Farber Cancer Institute, Boston, MA, USA., Huff CA; Johns Hopkins Hospital, Baltimore, MD, USA., Basile FG; Cape Cod Hospital, Hyannis, MA, USA., Wade PM; Cape Cod Hospital, Hyannis, MA, USA., Paba-Prada CE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Ghobrial IM; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Schlossman RL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Burke JN; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Harrington CC; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Lively KJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA., Lyons HF; Mass General/North Shore Cancer Center, Danvers, MA, USA., Munshi NC; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Anderson KC; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Trippa L; Dana-Farber Cancer Institute, Boston, MA, USA., Richardson PG; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Raje NS; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2018 Jul; Vol. 182 (2), pp. 222-230. Date of Electronic Publication: 2018 May 08.